john sayer retweeted
So, who would want to be a clinical academic?
As part of the @bmj_latest Commission on the Future of Academic Medicine, our article summarises some key challenges for the clinical academic workforce and opportunities for change ๐
@gillianvance4
bmj.com/content/392/bmj-2025โฆ
john sayer retweeted
Professor David Kavanagh from @NationalaHUS speaking about C3G at #UKKW2026
john sayer retweeted
Professor John Sayer and PKD Charityโs PPI officer Audrey Hughes showing that #KidneysMatter at UK Kidney Week!
#WorldKidneyDay #PKD #UKKW26
@kidneydayUK
john sayer retweeted
Check this recently published in @JournalofNeph
"Genetic testing to the rescue" highlighting the need for #GeneticNephrology in resource-limited settings
academic.oup.com/joneph/advaโฆ
@ISNkidneycare @IPNA_PedNeph @drjosflynn @johnasayer @Gawad_Nephro @dalatif @Rasha_Darwish_
john sayer retweeted
This #RareDiseaseDay we stand with people living with rare conditions in the UK and beyond, with their families, the people still searching for answers, and everyone who has lost someone along the way. ๐
john sayer retweeted
๐ Itโs #RareDiseaseDay 2026! ๐
Today we stand with the 300 million people living with a rare disease. Together, weโre showing our colours, raising awareness, and inspiring change by talking about what equity means to us.
๐ Read more: go.rarediseaseday.org/NEWS
john sayer retweeted
Thrilled to share that our research on splice modulation therapy for X-linked Alport syndrome using organoids as scalable preclinical models has just been published!
I am grateful to all co-authors and my mentors!
@JCI_insight @InstitutImagine @gdorval12
insight.jci.org/articles/vieโฆ
john sayer retweeted
Advancing regulatory variant effect prediction with AlphaGenome | โฆ@Natureโฉ โฆ@GoogleDeepMindโฉ nature.com/articles/s41586-0โฆ
john sayer retweeted
๐งฌ People living with a rare disease often wait years for answers.
๐ Equity means every person deserves the same chance to benefit from a treatment for their condition.
๐ Learn more: go.rarediseaseday.org/equity
#RareDiseaseDay #EquityForRare#TreatmentAccess

ALT โBlue-to-purple gradient graphic for Rare Disease Day. White text reads โ72% of rare diseases are geneticโ. Smaller text notes other causes include infections, allergies, environmental factors, or rare cancers. The date โ28 Feb 2026โ, the Rare Disease Day logo, โrarediseaseday.orgโ, โ#RareDiseaseDayโ, and a 2019 European Journal of Human Genetics reference appear on the image.โ
john sayer retweeted
๐ ๐ฒ๐ฒ๐ ๐ผ๐๐ฟ ๐ธ๐ฒ๐๐ป๐ผ๐๐ฒ ๐๐ฝ๐ฒ๐ฎ๐ธ๐ฒ๐ฟ๐ ๐ณ๐ผ๐ฟ #๐๐ถ๐น๐ถ๐ฎ๐ฎ๐ฌ๐ฎ๐ณ!
We are grateful for their participation and look forward to welcoming the cilia community on 8-12, March 2027.
Wishing you all a happy and inspiring 2026.
#Cilia #Milan
john sayer retweeted
Professor Michael Nicholson has been awarded an OBE in the Kingโs New Year Honours in recognition of services to kidney transplantation.
With funding from Kidney Research UK, he led the development of normothermic machine perfusion, an innovativeโฏtechnique that could mean more donor kidneys are suitable for transplantation and more people could receive life-changing surgery.
Sandra Currie, Kidney Research UK chief executive said: โ๐๐๐๐ โ๐๐ ๐๐๐๐ ๐๐ ๐๐ฅ๐ก๐๐๐๐๐๐๐๐๐๐ฆ ๐๐๐๐ก๐๐๐๐ข๐ก๐๐๐ ๐ก๐ ๐ก๐๐๐๐ ๐๐๐๐๐ก ๐ ๐๐๐๐๐๐ ๐๐๐ ๐กโ๐๐ โ๐๐๐๐ข๐ ๐๐๐๐๐๐๐ก๐ ๐๐๐กโ โ๐๐ ๐๐๐๐๐๐ข๐๐ ๐๐๐๐๐๐ก ๐๐ ๐กโ๐ ๐๐๐๐๐ ๐๐๐ โ๐๐ ๐๐ฅ๐๐๐๐ก๐๐๐๐๐ ๐๐๐๐๐๐ก๐๐๐๐ก ๐ก๐ ๐กโ๐ ๐๐๐๐๐๐ฆ ๐๐๐๐๐ข๐๐๐ก๐ฆ.
Congratulations to Professor Michael Nicholson, this recognition is truly well deserved.
Read our full response here: bit.ly/3YQFbuG
john sayer retweeted
๐ฃCalling all #ResidentDoctors & #MedicalStudents! Thinking about a career in Nephrology? Join our taster event!
Hear from renal registrars & consultants, learn about key conditions, explore career pathways & get tips for CVs & interviews.
๐ukkidney.org/health-professiโฆ
#Nephrology
john sayer retweeted
Celebrate this winner of the Distinguished Researcher Award, an ASN Midcareer Award: Simone Sanna-Cherchi MD. His research brings together investigators across disciplines and continents to study complex, understudied kidney conditions. Read more in #ASNKidneyNews: kidney.pub/KN1710-45
john sayer retweeted
๐จ LAST CHANCE! Early Bird registration for #UKKW26 closes tonight โฐ
๐ Join the UKโs largest event for kidney professionals
๐ธ Save 10% | 3-day pass from just ยฃ270 | No price increase from UKKW25
๐งฌ 50+ sessions | Expert speakers
๐ Register now: ukkw.org/registration
john sayer retweeted
This is your moment to shape #KidneyWk 2026 in Denver, CO. 12,000 faculty and participants made 2025 unforgettable. Share your ideas and recommendations to help build whatโs next.
๐
Submit by Monday, December 15, 2025
๐asn.kdny.info/OtYG50XpH73
john sayer retweeted
Praveen Dhondurao Sudhindar, John Sayer @johnasayer, Juliana Arcila-Galvis and colleagues @CILIAREN find that urinary renal epithelial cells can be used for NPHP1 phenotyping and a personalized therapeutic strategy.
#JCSciliaSI
journals.biologists.com/jcs/โฆ
john sayer retweeted
Read more about this research in our โFirst personโ interview with Praveen Dhondurao Sudhindar: journals.biologists.com/jcs/โฆ
#JCSciliaSI
john sayer retweeted
Exciting news for C3G! @ThePeanutKidney @kieranmccaffs - I should have done this hot off the press for journal club today!!
john sayer retweeted
The results from the APPEAR-C3G trial led by @DrDKavanagh has been published in the Lancet.
The trial looked at the safety profile and efficacy of iptacopan vs. placebo for the treatment of C3G.
thelancet.com/journals/lanceโฆ
john sayer retweeted
Luke was only 15 years old when he discovered he was living with polycystic kidney disease (PKD).
When it became clear that Luke was going into kidney failure, his mother, Gill, was adamant that she would donate a kidney to prevent him needing life-restricting dialysis treatment.
Now, two months on from a successful kidney transplant, Luke and Gill are sharing how live organ donation has already changed their lives in the most positive way.
Luke says: โOver the past few years I became increasingly tired and unable to stand for long periods because of my back pain. It was harder to keep up with social occasions, exercise, travelling, and, of course, my photography. The prospect of needing dialysis to keep me alive was frightening and Iโm so grateful to my mum for saving me from that.
โMy kidney function has fluctuated post-transplant and is currently around 50%. There is a long way to go but I am noticing a difference in how I was feeling before the transplant.
โIโll always be grateful to Mum for putting herself in this position to help me out. She is my hero. We have a great relationship, and I think this has strengthened that even more. Itโs special to always have a part of Mum with me.โ
Gill says: โThe last thing we wanted was for Luke to end up on dialysis which would have taken over his life. When it became clear he needed a transplant, it was a no-brainer for me to donate.
โItโs a daunting thought to have surgery and give up an organ. However, once Iโd spoken to another live organ donor and the doctors, I was reassured that my life wouldnโt be negatively affected living with one kidney. Iโm already proving that is the case. My kidney will have a far greater impact on Lukeโs life than my own.
โI did have some pain from the surgery and side-effects from the anaesthetic and morphine. I didnโt feel great for a few days, but it only took a couple of weeks to feel more back to normal. As time goes on, weโre both doing better.โ
โIโm doing really well now and just need check-up appointments to make sure everything is okay.
โIt is a relief to have had the transplant and be able to support Luke as his life gets back to more normality.โ
Is it inside you to save a life? If youโve already chosen to donate a kidney, or youโre simply curious about the process and what it entails, visit @DonateaKidneyUK to learn more.
Youโll find lots of resources, myth busting, and living donation support all in one place: bit.ly/47JmYmG






































